...
The Disruptors: Mapping the world’s genomic diversity October 17, 2019 The majority of genomic data comes from people with European ancestries, meaning 60pc of the world's population is represented by less than 5pc of current datasets. Global Gene Corp is changing that. Click here to watch the video It's a big task - mapping and organising the genomics diversity of the world - but for Sumit Jamuar, chairman and CEO of Global Gene Corp, the challenge is worth...
...
NPJ Genomic Medicine: Implementation of genomics in medical practice to deliver precision medicine for an Asian population September 5, 2019 Our Co-Chief Scientific Officer Saumya Jamuar and his team at SingHealth Duke-NUS Institute of Precision Medicine in Singapore have published a paper in the journal NPJ Genomic Medicine, examining the potential for bringing genomic medicine into routine medical practice in the country. Abstract: Whilst the underlying principles of precision medicine are comparable across the globe, genomic r...
...
maize interview with CEO Sumit Jamuar: The promise of precision medicine September 5, 2019 Our CEO Sumit Jamuar sat down with maize to talk about the promise of precision medicine and how it will affect healthcare in the future. Transcript: Precision medicine is the phenomenal promise in simple terms that we will be able to give the right drug to the right patient in the right dosage at the right time. And what it essentially means is that if you move away from treating ...
...
Technology Networks: More Diverse Genomic Databases Can Tackle Healthcare Inequalities September 5, 2019 Our Co-Chief Scientific Officers Saumya Jamuar and Jonathan Picker discuss the latest analysis showing that more than three quarters of genomes in genome-wide association studies (GWAS) are from people of European descent, looking at the implications of this lack of diversity and the steps that are being taken to rectify the situation - including our own projects in Africa and India. "One of...
...
Moonshot For Life: Democratising healthcare through genomics September 5, 2019 Our CEO Sumit Jamuar talks to Moonshot For Life about our moonshot: building a truly global genome to bring the promise of precision medicine to all. "When it first started, The Human Genome Project was based data from a handful of people with majority European ancestry. Today we know that there is incredible genetic variation all over the world, and that this impacts on health. Now the scie...
...
Drug Discovery World: From human genome to global genome – why precision medicine must address genetic diversity September 5, 2019 Our leadership team - Sumit Jamuar, Saumya Jamuar, Jonathan Picker and Yaron Turpaz - have an in-depth feature in the latest edition of Drug Discovery World, exploring the importance of incorporating genomic diversity into the drug discovery process. "The publication of the first human genome sequence more than 15 years ago marked the start of a new era in medicine. In the years since then, ...
...
HEALTHCARE IN THE AGE OF PRECISION MEDICINE September 18, 2018 — In the future, the standard techniques we use to cure disease will be considered medieval. A one-size fits all approach to drugs and other treatments will become a thing of the past. Each individual will finally be at the core of a fully-tailored, customisable healthcare plan. This year, 2018, marks the 15th anniversary of the draft sequence of the human genome – a milestone in healthcare in...
...
From Human Genome To Global Genome | Sumit Jamuar | TEDxRoma May 26, 2018 The Human Genome project tries to unlock the secrets of the DNA code. Genomics currently has a fatal flaw - lack of genomic data diversity; 81% of all genomic data comes from people of European heritage and our existing knowledge misses out data and insights from the majority of ethnicities that represent humanity. In this talk, Sumit Jamuar shares his perspective of why we need to move from th...
...
Company of the month – Global Gene Corp April 26, 2018 Each month we profile an innovative, growing company from across The Golden Triangle of Cambridge, London and Oxford. This month we speak to Sumit Jamuar, CEO of Global Gene Corp, a company that aims to democratise healthcare through genomics to positively disrupt health outcomes for every individual. Tell us about Global Gene Corp, especially the genomic sequencing work in South Asia. How i...
...
UK and US Firms Creates Largest Genomics Project to Study Indian Population March 19, 2018 UK-based genomics data platform Global Gene Corp and American genetics company, Regeneron Genetics Center announced yesterday that they will collaborate to create the world’s largest project of its kind to study Indian population. The multi-year-tie-up is aimed at finding innovative diagnosis and therapies for rare diseases. Genomic sequencing data generated by Regeneron Research Center will...